Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US9603863B2 · kind B2 · utility

41Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2015
Grant dateMar 28, 2017
Priority date
Expiry dateJun 22, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/7064
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.